University of Virginia: Heart Benefits and Health Concerns - Should You Take the New Weight-Loss Drugs?
August 11, 2023
August 11, 2023
CHARLOTTESVILLE, Virginia, Aug. 11 (TNSres) -- The University of Virginia issued the following research news:
The headlines surrounding a new class of weight-loss drugs fluctuate like a patient stepping on and off a scale.
The medications, based on the drug semaglutide, are celebrated as a miracle cure for obesity one day. On another, fears of serious complications arise.
But back on the positive side: Drugmaker Novo Nordisk announced Tuesday that its versi . . .
The headlines surrounding a new class of weight-loss drugs fluctuate like a patient stepping on and off a scale.
The medications, based on the drug semaglutide, are celebrated as a miracle cure for obesity one day. On another, fears of serious complications arise.
But back on the positive side: Drugmaker Novo Nordisk announced Tuesday that its versi . . .